Karazanishvili Levan, Limonjiani Eduard
EVEX Medical Corporation, Georgia.
Tbilisi State Medical University, Georgia.
Case Rep Surg. 2020 Dec 8;2020:4241204. doi: 10.1155/2020/4241204. eCollection 2020.
Malignant cardiac tumors are extremely rare, representing only 25% of all cardiac tumors, and angiosarcoma is the most common subtype. Myxofibrosarcomas are one of the rarest forms of cardiac malignant tumors. These tumors can silently grow and produce no or few symptoms until the tumor is large enough to obstruct blood flow. The definitive treatment is negative margin resection, if possible. Most cardiac tumors have a limited response to chemotherapy and radiotherapy. Therefore, surgical treatment is considered the best option. Our patient is a 57-year-old Caucasian postmenopausal female who presented with dyspnea, shortness of breath, and fatigue. Echocardiography confirmed the presence of a mass in the left atrium. A median sternotomy was performed with aortic and bicaval cannulation. Right atriotomy was performed, and the left atrium was exposed through the transseptal approach. A rounded smooth-surfaced mass was found in the left atrium that was 3.5 × 4.5 cm in size. The mass had a prominent and firm attachment point with a wide-based stalk in the pulmonary vein-right atrium border area. The tumor was completely excised, and the excision point was strengthened with a running suture. The following pathologic diagnosis was finally made: myxofibrosarcoma, FNCLCC (National Federation of Cancer Centres) Grade 2. Immunohistochemistry showed positivity for Epithelial membrane antigen (), desmin, calretinin, Ki67, Smooth Muscle Actin (), and S100. Given the rarity of cardiac malignant tumors, we thought preoperatively that this particular tumor could be a myxoma although it did not have the classical attachment point with a stalk at the interatrial septum. Our case is an example of how fast a cardiac sarcoma can grow. Nine months before the presentation, the patient underwent an echocardiography that did not show any signs of tumor growth. The estimated time of growth was 9 months or less. We followed our patient, performing a computer tomography scan and echocardiography 1 month after surgery, and these did not show any signs of tumor growth.
恶性心脏肿瘤极为罕见,仅占所有心脏肿瘤的25%,血管肉瘤是最常见的亚型。黏液纤维肉瘤是心脏恶性肿瘤中最罕见的形式之一。这些肿瘤可悄然生长,在肿瘤大到足以阻塞血流之前不产生或仅产生很少症状。如果可能,确定性治疗是切缘阴性切除。大多数心脏肿瘤对化疗和放疗反应有限。因此,手术治疗被认为是最佳选择。我们的患者是一名57岁的白种人绝经后女性,表现为呼吸困难、气短和乏力。超声心动图证实左心房存在肿块。采用主动脉和双腔静脉插管进行正中胸骨切开术。进行右心房切开术,并通过经房间隔途径暴露左心房。在左心房发现一个大小为3.5×4.5厘米的圆形、表面光滑的肿块。该肿块在肺静脉 - 右心房边界区域有一个突出且牢固的附着点,有一个宽基底蒂。肿瘤被完全切除,切除点用连续缝合加强。最终做出如下病理诊断:黏液纤维肉瘤,法国国立癌症中心联合会(FNCLCC)2级。免疫组化显示上皮膜抗原()、结蛋白、钙视网膜蛋白、Ki67、平滑肌肌动蛋白()和S100呈阳性。鉴于心脏恶性肿瘤的罕见性,我们术前认为这个特殊肿瘤可能是黏液瘤,尽管它没有在房间隔处带有蒂的典型附着点。我们的病例是心脏肉瘤生长速度有多快的一个例子。在就诊前九个月,患者接受了超声心动图检查,未显示任何肿瘤生长迹象。估计生长时间为9个月或更短。我们对患者进行了随访,术后1个月进行了计算机断层扫描和超声心动图检查,这些检查未显示任何肿瘤生长迹象。